Summary
Insights
Huma, a London-based digital health platform, shows significant potential due to its emphasis on predictive care and support for medical research. Utilizing a B2B SaaS model, Huma offers healthcare providers tools to predict patient health outcomes and streamline research processes, enabling faster diagnoses and more effective treatments compared to traditional methods. Backed by investors like Unilever Ventures and Samsung NEXT, Huma has strong financial support and credibility. With its innovative approach to integrating digital health data, Huma is well-positioned to disrupt the healthcare industry.
Total Funding
$235M
- Series D (2024) $80.0M
- Series C (2021-05-11) $130M
- Unknown (2020-01-01)
- Series B (2019-11-01) $25.0M
Investors
Hitachi Ventures Series D
AstraZeneca Series D
Unilever Ventures Series C
Samsung NEXT Series C
Sony Innovation Fund Series C
Full Company Profile
- Access details of the company management, and other intelligence on this company by registering for Seedtable